Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Novus Therapeutics, Inc.

14.60
0.0000
Volume:- -
Turnover:- -
Market Cap:221.34M
PE:-0.65
High:14.60
Open:14.60
Low:14.60
Close:14.60
52wk High:27.32
52wk Low:4.50
Shares:15.16M
Float Shares:8.16M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.5110
EPS(LYR):-24.4247
ROE:-21.07%
ROA:-7.29%
PB:10.29
PE(LYR):-0.60

Loading ...

OverviewCompanyNewsFilings

BRIEF-Novus Therapeutics Files Prospectus Related To Proposed Resale, Other Disposition Of 12.4 Mln Shares By Selling Stockholders

Reuters
·
Dec 12, 2020

12 Healthcare Stocks Moving In Wednesday's After-Market Session

Benzinga Staff Writer
·
Dec 02, 2020

BRIEF-Novus Therapeutics Reports Q3 2020 Financial Results

Reuters
·
Nov 17, 2020

Novus Therapeutics Q3 EPS $(5.51) Down From $(4.01) YoY

Benzinga
·
Nov 17, 2020

BRIEF-Novus Therapeutics Announces First Patient Enrolled In Phase 2A Clinical Trial Of Anti-Cd40l Antibody At-1501 In Amyotrophic Lateral Sclerosis

Reuters
·
Nov 02, 2020

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:52 PM

Reuters
·
Oct 29, 2020

Analyst Rate

 
 
 
 

Corporate Actions

Symbol Change
Jan 05, 2021 ELDN
Financial Report Announcement
Nov 16, 2020 Post Market
Split&Reverse Split
Oct 05, 2020 18 for 1
Financial Report Announcement
Mar 17, 2020
Financial Report Announcement
Aug 13, 2019

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.65
Current
-3.54
Sector Average
65.65%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.65
Maximum
--
+1 STD
-0.26
Minimum
--
-1 STD
-6.82
Average
-3.54

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.